BRAF and papillary carcinoma: This distribution aligns with the known mutational landscape of indeterminate thyroid nodules, in which RAS-type mutations predominate in follicular-patterned lesions, whereas BRAF V600E is typically associated with papillary carcinoma morphology [13].